
Benny Quoc Tieu
Supervisory Patent Examiner (ID: 2443, Phone: (571)272-7490 , Office: P/2674 )
| Most Active Art Unit | 2642 |
| Art Unit(s) | 2614, 2642, 2625, 2742, 2674, 2682 |
| Total Applications | 759 |
| Issued Applications | 578 |
| Pending Applications | 87 |
| Abandoned Applications | 103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15206317
[patent_doc_number] => 20190365845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
[patent_app_type] => utility
[patent_app_number] => 16/168777
[patent_app_country] => US
[patent_app_date] => 2018-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16168777
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/168777 | METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE | Oct 22, 2018 | Abandoned |
Array
(
[id] => 14406845
[patent_doc_number] => 20190169266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => CONSTRUCTS HAVING A SIRP-ALPHA DOMAIN OR VARIANT THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/153404
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/153404 | Constructs having a SIRP-alpha domain or variant thereof | Oct 4, 2018 | Issued |
Array
(
[id] => 16206530
[patent_doc_number] => 20200239520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => ANTICANCER PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/753627
[patent_app_country] => US
[patent_app_date] => 2018-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/753627 | Anticancer peptides and uses thereof | Oct 3, 2018 | Issued |
Array
(
[id] => 14045921
[patent_doc_number] => 20190079067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => NANOPORE PROTEIN CONJUGATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/146053
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16146053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/146053 | Nanopore protein conjugates and uses thereof | Sep 27, 2018 | Issued |
Array
(
[id] => 14501183
[patent_doc_number] => 20190194246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => SOLID PHASE PEPTIDE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 16/143917
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16143917
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/143917 | SOLID PHASE PEPTIDE SYNTHESIS | Sep 26, 2018 | Abandoned |
Array
(
[id] => 18128853
[patent_doc_number] => 11555052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Methods for preventing disulfide bond reduction in cell culture harvest with selenite
[patent_app_type] => utility
[patent_app_number] => 16/648014
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 4281
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648014 | Methods for preventing disulfide bond reduction in cell culture harvest with selenite | Sep 25, 2018 | Issued |
Array
(
[id] => 14069519
[patent_doc_number] => 20190083647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/143147
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16143147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/143147 | Virus-like particle conjugates for diagnosis and treatment of tumors | Sep 25, 2018 | Issued |
Array
(
[id] => 17938394
[patent_doc_number] => 11472835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Integrated automated filtration for separation, washing and drying of peptide crystals
[patent_app_type] => utility
[patent_app_number] => 16/650772
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 3721
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650772 | Integrated automated filtration for separation, washing and drying of peptide crystals | Sep 18, 2018 | Issued |
Array
(
[id] => 16168232
[patent_doc_number] => 10709772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Use of botulinum neurotoxin in the treatment of sialorrhea
[patent_app_type] => utility
[patent_app_number] => 16/129311
[patent_app_country] => US
[patent_app_date] => 2018-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10285
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16129311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/129311 | Use of botulinum neurotoxin in the treatment of sialorrhea | Sep 11, 2018 | Issued |
Array
(
[id] => 14438999
[patent_doc_number] => 20190177372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => Process for the Preparation of Cyclic Depsipeptides
[patent_app_type] => utility
[patent_app_number] => 16/127399
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16127399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/127399 | Process for the preparation of cyclic depsipeptides | Sep 10, 2018 | Issued |
Array
(
[id] => 16275582
[patent_doc_number] => 10758589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Chloride salt of TAT-NR2B9c
[patent_app_type] => utility
[patent_app_number] => 16/128423
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17903
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16128423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/128423 | Chloride salt of TAT-NR2B9c | Sep 10, 2018 | Issued |
Array
(
[id] => 17281693
[patent_doc_number] => 11198713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Agents modulating beta-catenin functions and methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/645407
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 54883
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645407 | Agents modulating beta-catenin functions and methods thereof | Sep 6, 2018 | Issued |
Array
(
[id] => 16807844
[patent_doc_number] => 20210130397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => METHODS FOR PURIFYING ANTIBODIES HAVING REDUCED HIGH MOLECULAR WEIGHT AGGREGATES
[patent_app_type] => utility
[patent_app_number] => 16/640755
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640755 | Methods for purifying antibodies having reduced high molecular weight aggregates | Aug 21, 2018 | Issued |
Array
(
[id] => 17665302
[patent_doc_number] => 11358983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Method of purifying glycosylated protein from host cell galectins and other contaminants
[patent_app_type] => utility
[patent_app_number] => 16/630458
[patent_app_country] => US
[patent_app_date] => 2018-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 53
[patent_no_of_words] => 22864
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630458 | Method of purifying glycosylated protein from host cell galectins and other contaminants | Aug 17, 2018 | Issued |
Array
(
[id] => 16087831
[patent_doc_number] => 20200197902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => SUPRAMOLECULAR FILAMENTOUS ASSEMBLIES FOR PROTEIN PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/639763
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639763 | Supramolecular filamentous assemblies for protein purification | Aug 16, 2018 | Issued |
Array
(
[id] => 15724315
[patent_doc_number] => 10610572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action
[patent_app_type] => utility
[patent_app_number] => 16/048007
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 12188
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16048007
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/048007 | Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action | Jul 26, 2018 | Issued |
Array
(
[id] => 16246113
[patent_doc_number] => 10745454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Method of synthesizing antagonist peptides for cell growth
[patent_app_type] => utility
[patent_app_number] => 16/042284
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 14167
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042284
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/042284 | Method of synthesizing antagonist peptides for cell growth | Jul 22, 2018 | Issued |
Array
(
[id] => 16190796
[patent_doc_number] => 20200231645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => Bifunctional compounds
[patent_app_type] => utility
[patent_app_number] => 16/632007
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632007
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632007 | Bifunctional compounds | Jul 18, 2018 | Issued |
Array
(
[id] => 17266369
[patent_doc_number] => 11191773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Methods of treatment for bacterial infections
[patent_app_type] => utility
[patent_app_number] => 16/631717
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 47
[patent_no_of_words] => 13859
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631717 | Methods of treatment for bacterial infections | Jul 15, 2018 | Issued |
Array
(
[id] => 16267346
[patent_doc_number] => 20200268833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/629711
[patent_app_country] => US
[patent_app_date] => 2018-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629711
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629711 | Compositions and methods for the treatment of fungal infections | Jul 10, 2018 | Issued |